Contrast Induced Nephropathy - Pipeline Review, H2 2017

Publisher Name :
Date: 08-Aug-2017
No. of pages: 38
Inquire Before Buying

Contrast Induced Nephropathy - Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Contrast Induced Nephropathy - Pipeline Review, H2 2017, provides an overview of the Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline landscape.

Contrast-induced nephropathy (CIN) is defined as the impairment of renal function (measured as either a 25%increase in serum creatinine (SCr) from baseline or a 0.5 mg/dL (44 µmol/L) increase in absolute SCr value after 48-72 hrs contrast administration). Symptoms include feeling more tired, poor appetite, swelling in the feet and ankles, puffiness around the eyes, or dry and itchy skin. Risk factors include age, diabetes, decreased kidney function and congestive heart failure. Treatment includes electrolyte management.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Contrast Induced Nephropathy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Contrast Induced Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Preclinical stages are 1 and 4 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones).

- The pipeline guide reviews pipeline therapeutics for Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Contrast Induced Nephropathy - Pipeline Review, H2 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Contrast Induced Nephropathy - Overview
Contrast Induced Nephropathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Contrast Induced Nephropathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Contrast Induced Nephropathy - Companies Involved in Therapeutics Development
Pharming Group NV
Contrast Induced Nephropathy - Drug Profiles
C1 esterase inhibitor (recombinant) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-190 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-801 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-901 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-911 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides to Agonize PACAP Receptors for Oncology, Cardiovascular and Kidney Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Contrast Induced Nephropathy - Dormant Projects
Contrast Induced Nephropathy - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Contrast Induced Nephropathy, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Contrast Induced Nephropathy - Pipeline by Pharming Group NV, H2 2017
Contrast Induced Nephropathy - Dormant Projects, H2 2017
Contrast Induced Nephropathy - Discontinued Products, H2 2017

List of Figures
Number of Products under Development for Contrast Induced Nephropathy, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
  • Global and United States Peritoneal Dialysis Solution Market Research by Company, Type & Application 2013-2025
    Published: 07-Jul-2018        Price: US 2000 Onwards        Pages: 103
    Summary Market Segment as follows: By Type - Containing 1.5% Glucose Type - Containing 2.5% Glucose Type - Containing 4.25% Glucose Type By Application - CAPD - APD By Company - Fresenius - Baxter - B. Braun - Terumo - Huaren - CR Double-Crane - Qingshan Likang - Tj Tianan The main contents of the report including: Section 1: Produc......
  • Global Hemodialysis Concentrates Market Research Report 2018
    Published: 06-Jul-2018        Price: US 2900 Onwards        Pages: 94
    This report studies the global Hemodialysis Concentrates market status and forecast, categorizes the global Hemodialysis Concentrates market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Hemodialysis Concentrates market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during ......
  • 2013-2023 Global Polycystic Kidney Disease Drug Industry Report
    Published: 05-Jul-2018        Price: US 4000 Onwards        Pages: 145
    The global market size of Polycystic Kidney Disease Drug is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This repo......
  • Global Extracorporeal Shock Wave Lithotripsy (ESWL) Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 28-Jun-2018        Price: US 3480 Onwards        Pages: 153
    Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in hospital. Scope of the Report: This report focuses on the Extracorporeal Shock Wave Lithotripsy (ESWL) in global market, especially in North America, Europe and Asia-Pacific, South Amer......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Extracorporeal Shock Wave Lithotripsy (ESWL) Market 2018, Forecast to 2023
    Published: 28-Jun-2018        Price: US 4880 Onwards        Pages: 153
    Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in hospital. Scope of the Report: This report focuses on the Extracorporeal Shock Wave Lithotripsy (ESWL) in global market, especially in North America, Europe and Asia-Pacific, South Amer......
  • 2018-2023 Global Extracorporeal Shock Wave Lithotripsy (ESWL) Consumption Market Report
    Published: 08-Jun-2018        Price: US 4660 Onwards        Pages: 167
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Extracorporeal Shock Wave Lithotripsy (ESWL) market for 2018-2023. Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in......
  • 2018 Top 5 Extracorporeal Shock Wave Lithotripsy (ESWL) Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 08-Jun-2018        Price: US 4960 Onwards        Pages: 146
    Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones (urinary calculus) and biliary calculi (stones in the gallbladder or in the liver) using an acoustic pulse. It is also reported to be used for salivary stones and pancreatic stones. It is mainly used in hospital. ESWL machine is one of the fastest growing directions in the field of large-scale medical equipment. ESWL machine industry has maintained a rapid growth rate. Currently, ESWL machine market ......
  • Global Hemodialysis Concentrates Market Research Report to 2018
    Published: 20-May-2018        Price: US 3500 Onwards        Pages: 114
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Acid Concentrates - Bicarbonate Concentrates By Application - Dialysis Center - Home By Company - Fresenius Medical Care - Baxter - B. Braun - Rockwell Medical - Nipro - MEDIVATORS - Dia......
  • Global Hemodialysis Concentrates Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 16-May-2018        Price: US 3480 Onwards        Pages: 100
    Hemodialysis concentrates including... Scope of the Report: This report focuses on the Hemodialysis Concentrates in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications. Market Segment by Manufacturers, this report covers - Fresenius Medical Care - Baxter - B. Braun - Rockwell Medica......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs